Cargando…

Xanthine oxidase inhibitor urate-lowering therapy titration to target decreases serum free fatty acids in gout and suppresses lipolysis by adipocytes

OBJECTIVE: Linked metabolic and cardiovascular comorbidities are prevalent in hyperuricemia and gout. For mechanistic insight into impact on inflammatory processes and cardiometabolic risk factors of xanthine oxidase inhibitor urate-lowering therapy (ULT) titration to target, we performed a prospect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guma, Monica, Dadpey, Benyamin, Coras, Roxana, Mikuls, Ted R., Hamilton, Bartlett, Quehenberger, Oswald, Thorisdottir, Hilda, Bittleman, David, Lauro, Kimberly, Reilly, Shannon M., Liu-Bryan, Ru, Terkeltaub, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310412/ https://www.ncbi.nlm.nih.gov/pubmed/35879786 http://dx.doi.org/10.1186/s13075-022-02852-4

Ejemplares similares

Integrated safety studies of the urate reabsorption inhibitor lesinurad in treatment of gout
por: Terkeltaub, Robert, et al.
Publicado: (2019)

Urate in fingernail represents the deposition of urate burden in gout patients
por: Chen, Haibing, et al.
Publicado: (2020)

Differences in oxylipin profile in psoriasis versus psoriatic arthritis
por: Coras, Roxana, et al.
Publicado: (2021)

Gout. Novel therapies for treatment of gout and hyperuricemia
por: Terkeltaub, Robert
Publicado: (2009)

Variation in serum urate levels in the absence of gout and urate lowering therapy
por: Shaffer, Andrew, et al.
Publicado: (2021)

Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients
por: Ran, Zijing, et al.
Publicado: (2021)

Influence of Dietary n-3 Long Chain Polyunsaturated Fatty Acid Intake on Oxylipins in Erythrocytes of Women with Rheumatoid Arthritis
por: Lindqvist, Helen M., et al.
Publicado: (2023)

Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress
por: George, Jacob, et al.
Publicado: (2009)

The role of urate and xanthine oxidase in vascular oxidative stress: future directions
por: George, Jacob, et al.
Publicado: (2009)

Adherence with urate-lowering therapies for the treatment of gout
por: Harrold, Leslie R, et al.
Publicado: (2009)

Systemic Urate Deposition: An Unrecognized Complication of Gout?
por: Khanna, Puja, et al.
Publicado: (2020)

Urate‐lowering therapy for patients with gout on hemodialysis
por: Alkilany, Reem, et al.
Publicado: (2022)

The relationship between ferritin and urate levels and risk of gout
por: Fatima, Tahzeeb, et al.
Publicado: (2018)

Coevolution of URAT1 and Uricase during Primate Evolution: Implications for Serum Urate Homeostasis and Gout
por: Tan, Philip K., et al.
Publicado: (2016)

Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney
por: Miner, Jeffrey, et al.
Publicado: (2016)

Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study
por: Uhlig, T., et al.
Publicado: (2022)

Effect of Fenofibrate in Combination with Urate Lowering Agents in Patients with Gout
por: Lee, You-Hyun, et al.
Publicado: (2006)

Treatment approaches and adherence to urate-lowering therapy for patients with gout
por: Aung, Thanda, et al.
Publicado: (2017)

Clinical Image: In vivo urate spherulites in a patient with gout
por: Pirker, Ian, et al.
Publicado: (2021)

Erratum to: Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney
por: Miner, Jeffrey N., et al.
Publicado: (2016)

Feasibility of conducting a randomized, placebo-controlled study assessing whether omega-3 fatty acids prevent gout flares when starting urate-lowering treatment
por: Abhishek, Abhishek, et al.
Publicado: (2022)

Characterization of an Anti-gout Xanthine Oxidase Inhibitor from Pleurotus ostreatus
por: Jang, In-Taek, et al.
Publicado: (2014)

The inflammatory process of gout and its treatment
por: Cronstein, Bruce N, et al.
Publicado: (2006)

Replication of Gout/Urate Concentrations GWAS Susceptibility Loci Associated with Gout in a Han Chinese Population
por: Li, Zhiqiang, et al.
Publicado: (2017)

Anti-Hyperuricemic Effects of Astaxanthin by Regulating Xanthine Oxidase, Adenosine Deaminase and Urate Transporters in Rats
por: Le, Yanzuo, et al.
Publicado: (2020)

The Effect of Decrease in Serum Urate for the Risk of Gout Flares During Urate-Lowering Therapy Initiation Among Chinese Male Gout Patients: A Prospective Cohort Study
por: Pang, Lei, et al.
Publicado: (2023)

Urate-lowering treatment and risk of total joint replacement in patients with gout
por: Kuo, Chang-Fu, et al.
Publicado: (2018)

Effects of multiple genetic loci on the pathogenesis from serum urate to gout
por: Dong, Zheng, et al.
Publicado: (2017)

Slowly melting the urate snow in joints: Explaining gout attacks to patients
por: Shimizu, Toru, et al.
Publicado: (2021)

Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout
por: Yen, Fu-Shun, et al.
Publicado: (2021)

Dose-response meta-analysis on urate, gout, and the risk for Parkinson’s disease
por: Chang, Hongtao, et al.
Publicado: (2022)

Elevated serum CA72-4 predicts gout flares during urate lowering therapy initiation: a prospective cohort study
por: Hu, Shuhui, et al.
Publicado: (2022)

Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
por: Wrigley, Rebekah, et al.
Publicado: (2020)

Effect of omega-three supplementation on serum urate and gout flares in people with gout; a pilot randomized trial
por: Stamp, Lisa K., et al.
Publicado: (2022)

Effects of ChondroT on potassium Oxonate-induced Hyperuricemic mice: downregulation of xanthine oxidase and urate transporter 1
por: Oh, Dool-Ri, et al.
Publicado: (2019)

Circulating Pro- and Anti-Inflammatory Metabolites and Its Potential Role in Rheumatoid Arthritis Pathogenesis
por: Coras, Roxana, et al.
Publicado: (2020)

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
por: Becker, Michael A, et al.
Publicado: (2010)

The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age
por: Jackson, Robert L, et al.
Publicado: (2012)

Impact of diuretics on the urate lowering therapy in patients with gout: analysis of an inception cohort
por: Ranieri, Laura, et al.
Publicado: (2018)

A Detailed Analysis of the Association between Urate Deposition and Erosions and Osteophytes in Gout
por: Pecherstorfer, Caroline, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l4jstoau25quu7gdbv5od29pcc